HIGHLIGHTS
- who: Haijun Xiao from the Department of Orthopedics, Shanghai Fenxian District Central Hospital/Anhui University of Science and Technology Hospital of Soochow University, Suzhou, China have published the research: A Network Pharmacology Study: Reveal the Mechanisms of Palovarotene Against Heterotopic Ossification, in the Journal: (JOURNAL)
- what: The primer sequences used in this study shown in Table 2. This study attempted to clarify a key target and mechanism of Palovarotene in the treatment of heterotopic ossification, screened out the possible core targets and related signaling pathways by means of network pharmacology, and carried out verification experiments . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.